Floatz logo

Cariprazine

Mania

AbbVieSmall moleculePhase 3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Mania cohort.

Asset / SponsorPhaseRating
Risperdal
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 4BBB
LITHIUM, ELEMENTAL
University of Cincinnati
Phase 4BBB
Seroquel®
University of Cincinnati
Phase 4BBB
Opc-34712
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3BB
Valproic Acid
Weill Medical College of Cornell University
Phase 4BB

View all 28 →

Same molecule, other indications

Cariprazine is also rated in:

bipolar I disorderDormant
BBB
Indicative ·
73 / 100
View asset →
Depression, BipolarDormant
BB
Indicative ·
71 / 100
View asset →
schizophreniaDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →